Zealand Pharma A/S (ZEAL) — Net Asset Momentum
Zealand Pharma A/S (ZEAL) recorded a net asset momentum of 72.1% as of December 2025, with net assets of Dkr14.83 Billion DKK. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See ZEAL net asset value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Zealand Pharma A/S Net Asset Momentum (2007–2025)
This chart tracks Zealand Pharma A/S's year-over-year net asset growth across 19 annual reporting periods from 2007 to 2025. The most recent momentum reading is +72.1%, with net assets of Dkr14.83 Billion DKK as of December 2025. For live market cap and overall valuation, see Zealand Pharma A/S (ZEAL) market capitalisation.
Annual Net Asset History for Zealand Pharma A/S (2007–2025)
The table below shows the complete annual net asset history for Zealand Pharma A/S from 2007 to 2025, covering 19 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Zealand Pharma A/S (ZEAL) tangible net worth to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (DKK) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | Dkr14.83 Billion | Dkr16.46 Billion | Dkr1.63 Billion | ▲ +72.1% |
| 2024 | Dkr8.62 Billion | Dkr9.51 Billion | Dkr888.86 Million | ▲ +441.0% |
| 2023 | Dkr1.59 Billion | Dkr1.98 Billion | Dkr387.15 Million | ▲ +95.2% |
| 2022 | Dkr815.91 Million | Dkr1.54 Billion | Dkr723.89 Million | ▼ -12.1% |
| 2021 | Dkr927.80 Million | Dkr2.07 Billion | Dkr1.14 Billion | ▼ -21.2% |
| 2020 | Dkr1.18 Billion | Dkr1.92 Billion | Dkr747.52 Million | ▼ -5.3% |
| 2019 | Dkr1.24 Billion | Dkr1.60 Billion | Dkr356.84 Million | ▲ +11.3% |
| 2018 | Dkr1.12 Billion | Dkr1.23 Billion | Dkr113.52 Million | ▲ +111.2% |
| 2017 | Dkr528.47 Million | Dkr737.24 Million | Dkr208.77 Million | ▲ +90.0% |
| 2016 | Dkr278.19 Million | Dkr694.63 Million | Dkr416.43 Million | ▲ +10.3% |
| 2015 | Dkr252.23 Million | Dkr634.69 Million | Dkr382.46 Million | ▼ -0.2% |
| 2014 | Dkr252.83 Million | Dkr596.76 Million | Dkr343.93 Million | ▼ -20.0% |
| 2013 | Dkr316.14 Million | Dkr346.91 Million | Dkr30.77 Million | ▼ -35.6% |
| 2012 | Dkr491.01 Million | Dkr522.40 Million | Dkr31.39 Million | ▲ +11.2% |
| 2011 | Dkr441.40 Million | Dkr469.48 Million | Dkr28.08 Million | ▲ +8.4% |
| 2010 | Dkr407.11 Million | Dkr450.55 Million | Dkr43.44 Million | ▲ +206.3% |
| 2009 | Dkr132.92 Million | Dkr158.68 Million | Dkr25.75 Million | ▼ -36.3% |
| 2008 | Dkr208.63 Million | Dkr225.24 Million | Dkr16.61 Million | ▼ -13.9% |
| 2007 | Dkr242.37 Million | Dkr263.37 Million | Dkr21.00 Million | — |